Abeona Therapeutics Inc

ABEO · Moat type: REGULIERUNG

MoatScore

3/10

Fair Value

n/a

Margin of Safety

n/a

Rating

SCHWACH

Abeona Therapeutics develops and commercializes cell-based and gene therapeutic treatments for rare hereditary diseases, with revenues primarily derived from commercial distribution of approved therapies as well as from milestone and licensing payments.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.